Transpire Bio to Present at the 2026 BIO International Convention
SUNRISE, Fla., June 18, 2026 /PRNewswire/ -- Transpire Bio Inc., an integrated, U.S.-based, clinical-stage biopharmaceutical company, announced today that its Chief Financial Officer, LaDuane Clifton, will present a company overview at the 2026 BIO International Convention. The convention...
SUNRISE, Fla., June 18, 2026 /PRNewswire/ -- Transpire Bio Inc., an integrated, U.S.-based, clinical-stage biopharmaceutical company, announced today that its Chief Financial Officer, LaDuane Clifton, will present a company overview at the 2026 BIO International Convention. The convention...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.